In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

It was a busy week for the biotech sector, as the fourth-quarter earnings season is in full swing. While Gilead Sciences, Inc ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The absence of major catalysts in the second half of 2024 could potentially lead to subdued stock performance for Xencor in the near term. Biotechnology stocks often rely on positive clinical ...

Regeneron (NASDAQ:REGN) Pharmaceuticals, a leading biotechnology company with a market ... According to InvestingPro analysis, the company's stock is currently trading near its 52-week low ...

Perhaps a deepening relationship with Nvidia could help nudge the firm to make the most of the ongoing AI boom as it sweeps through biotech. Either way, the stock looks to be flying under the ...

Is this biotech stock a no-brainer buy now after its huge FDA approval? How significant is FDA approval of Journavx for Vertex? Vertex CEO Reshma Kewalramani described the FDA approval of Journavx ...

In the last two decades, an exciting biotech market has emerged on the Toronto Stock Exchange (TSX). While most of these stocks are still small caps, many have the innovation and research to grow ...